TP53 and esophageal squamous cell carcinoma: Based on the results of this review, the following markers should be considered in actual clinical practice, although not with sufficient accuracy, and further findings are expected in the future: SCC‐Ag is useful for screening ESCC, and its sensitivity may be enhanced by adding CYFRA21‐1 or serum p53 antibodies.